CFAP161
gene geneOn this page
Also known as FLJ38615
Summary
CFAP161 (cilia and flagella associated protein 161, HGNC:26782) is a protein-coding gene on chromosome 15q25.1, encoding Cilia- and flagella-associated protein 161 (Q6P656). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Predicted to be involved in cilium assembly and flagellated sperm motility. Located in axonemal microtubule.
Source: NCBI Gene 161502 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 54 total
- MANE Select transcript:
NM_173528
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26782 |
| Approved symbol | CFAP161 |
| Name | cilia and flagella associated protein 161 |
| Location | 15q25.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ38615 |
| Ensembl gene | ENSG00000156206 |
| Ensembl biotype | protein_coding |
| Entrez | 161502 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000286732, ENST00000560091, ENST00000561216
RefSeq mRNA: 2 — MANE Select: NM_173528
NM_001353365, NM_173528
CCDS: CCDS42068
Canonical transcript exons
ENST00000286732 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001253114 | 81143662 | 81143820 |
| ENSE00001253121 | 81138051 | 81138135 |
| ENSE00002434177 | 81148338 | 81149179 |
| ENSE00002530819 | 81147858 | 81147931 |
| ENSE00002561855 | 81134270 | 81134398 |
| ENSE00003663949 | 81135270 | 81135359 |
| ENSE00003788617 | 81136516 | 81136748 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 87.95.
FANTOM5 (CAGE): breadth broad, TPM avg 1.2839 / max 144.8573, expressed in 252 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 148061 | 0.6829 | 108 |
| 148062 | 0.1771 | 51 |
| 148060 | 0.1313 | 50 |
| 148057 | 0.1175 | 38 |
| 148059 | 0.0988 | 48 |
| 148063 | 0.0553 | 29 |
| 148056 | 0.0210 | 6 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 87.95 | gold quality |
| monocyte | CL:0000576 | 87.55 | gold quality |
| leukocyte | CL:0000738 | 86.04 | gold quality |
| bronchial epithelial cell | CL:0002328 | 85.66 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.01 | gold quality |
| bronchus | UBERON:0002185 | 83.86 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 82.96 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 78.63 | gold quality |
| fallopian tube | UBERON:0003889 | 69.43 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 69.25 | gold quality |
| nasopharynx | UBERON:0001728 | 69.24 | gold quality |
| left testis | UBERON:0004533 | 68.34 | gold quality |
| right testis | UBERON:0004534 | 67.27 | gold quality |
| oviduct epithelium | UBERON:0004804 | 67.24 | gold quality |
| testis | UBERON:0000473 | 67.19 | gold quality |
| right lung | UBERON:0002167 | 66.32 | gold quality |
| sperm | CL:0000019 | 66.18 | silver quality |
| granulocyte | CL:0000094 | 65.59 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.22 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 64.41 | gold quality |
| upper lobe of lung | UBERON:0008948 | 64.03 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 63.45 | gold quality |
| adenohypophysis | UBERON:0002196 | 62.54 | gold quality |
| lung | UBERON:0002048 | 61.49 | gold quality |
| pituitary gland | UBERON:0000007 | 61.02 | gold quality |
| calcaneal tendon | UBERON:0003701 | 60.04 | gold quality |
| secondary oocyte | CL:0000655 | 59.00 | gold quality |
| lower lobe of lung | UBERON:0008949 | 58.48 | silver quality |
| hypothalamus | UBERON:0001898 | 58.07 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 58.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.77 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
41 targeting CFAP161, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-8084 | 99.73 | 69.57 | 1760 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-2053 | 99.57 | 69.15 | 1635 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-4650-3P | 99.01 | 68.39 | 1062 |
| HSA-MIR-154-5P | 98.92 | 66.65 | 733 |
| HSA-MIR-873-5P | 98.84 | 66.90 | 1348 |
| HSA-MIR-4451 | 98.82 | 68.17 | 1455 |
| HSA-MIR-455-5P | 98.74 | 67.31 | 795 |
| HSA-MIR-12114 | 98.70 | 63.45 | 730 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cfap161 | ENSDARG00000018281 |
| mus_musculus | Cfap161 | ENSMUSG00000011154 |
| rattus_norvegicus | Cfap161 | ENSRNOG00000012301 |
| drosophila_melanogaster | CG15498 | FBGN0038892 |
| drosophila_melanogaster | CG34457 | FBGN0085486 |
Protein
Protein identifiers
Cilia- and flagella-associated protein 161 — Q6P656 (reviewed: Q6P656)
All UniProt accessions (3): Q6P656, H0YM05, H0YNS7
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme. Flagellum axoneme.
Tissue specificity. Expressed in airway epithelial cells.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6P656-1 | 1 | yes |
| Q6P656-2 | 2 |
RefSeq proteins (2): NP_001340294, NP_775799* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR055325 | CF161 | Family |
Pfam: PF24569
UniProt features (6 total): splice variant 3, chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7UNG | ELECTRON MICROSCOPY | 3.6 |
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P656-F1 | 87.29 | 0.63 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 78 (showing top):
FREAC2_01, SP3_Q3, AAAYRNCTG_UNKNOWN, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_CILIUM_ORGANIZATION, GATA6_01, GOBP_CILIUM_MOVEMENT, TCF11_01, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, HP1SITEFACTOR_Q6, GOBP_ORGANELLE_ASSEMBLY, NKX22_01, P300_01, GOBP_CELL_PROJECTION_ORGANIZATION, TGGAAA_NFAT_Q4_01
GO Biological Process (2): flagellated sperm motility (GO:0030317), cilium assembly (GO:0060271)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): axonemal microtubule (GO:0005879), motile cilium (GO:0031514), sperm flagellum (GO:0036126), axonemal A tubule inner sheath (GO:0160111), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| binding | 1 |
| cytoplasmic microtubule | 1 |
| axoneme | 1 |
| cilium | 1 |
| 9+2 motile cilium | 1 |
| A axonemal microtubule | 1 |
| axonemal microtubule doublet inner sheath | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
820 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP161 | LRRC46 | Q96FV0 | 644 |
| CFAP161 | TEKTIP1 | A6NCJ1 | 595 |
| CFAP161 | PEBP4 | Q96S96 | 561 |
| CFAP161 | RSPH14 | Q9UHP6 | 540 |
| CFAP161 | LRRC23 | Q53EV4 | 539 |
| CFAP161 | SPATA18 | Q8TC71 | 538 |
| CFAP161 | CCDC146 | Q8IYE0 | 518 |
| CFAP161 | ODF2 | Q5BJF6 | 508 |
| CFAP161 | LRRC34 | Q8IZ02 | 502 |
| CFAP161 | DRC2 | Q8IXS2 | 501 |
| CFAP161 | CFAP52 | Q8N1V2 | 498 |
| CFAP161 | BET1L | Q9NYM9 | 488 |
| CFAP161 | TSNAXIP1 | Q2TAA8 | 487 |
| CFAP161 | MORN5 | Q5VZ52 | 477 |
| CFAP161 | DRC7 | Q8IY82 | 465 |
IntAct
25 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFAP161 | DPYSL5 | psi-mi:“MI:0915”(physical association) | 0.640 |
| CFAP161 | CINP | psi-mi:“MI:0915”(physical association) | 0.560 |
| BCL6 | CFAP161 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EFHC1 | CFAP161 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CFAP161 | NBN | psi-mi:“MI:0914”(association) | 0.350 |
| CFAP161 | BUB1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CFAP161 | MRE11 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CFAP161 | EML5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCDC150 | CFAP161 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RAD50 | CFAP161 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DPYSL5 | CFAP161 | psi-mi:“MI:0915”(physical association) | 0.000 |
| DCTPP1 | CFAP161 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CFAP161 | AFG2A | psi-mi:“MI:0915”(physical association) | 0.000 |
| CFAP161 | AFG2B | psi-mi:“MI:0915”(physical association) | 0.000 |
| BCL6 | CFAP161 | psi-mi:“MI:0915”(physical association) | 0.000 |
| EFHC1 | CFAP161 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CINP | CFAP161 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (17): C15orf26 (Affinity Capture-MS), C15orf26 (Affinity Capture-MS), EML5 (Affinity Capture-MS), SPATA5L1 (Affinity Capture-MS), MRE11A (Affinity Capture-MS), SPATA5 (Affinity Capture-MS), C15orf26 (Affinity Capture-MS), BUB1 (Affinity Capture-MS), C15orf26 (Affinity Capture-MS), C15orf26 (Two-hybrid), C15orf26 (Two-hybrid), C15orf26 (Two-hybrid), DPYSL5 (Two-hybrid), MRE11A (Affinity Capture-MS), NBN (Affinity Capture-MS)
ESM2 similar proteins: A0A8I6ASZ5, A2ARP1, A6QQP7, A7Z050, B0R034, D2HRF1, D3Z8X7, E1BPN0, F1RA39, F6QZ15, F6RJC2, O02019, O60308, O70311, O75923, O77682, P0C644, P19687, P29993, P33402, P57075, Q08CH3, Q08DJ7, Q14B46, Q1LZ50, Q24498, Q4R7D0, Q568D2, Q5R5N9, Q5RDF1, Q5SW45, Q5SY16, Q5U2Z5, Q5XGX5, Q6GQ76, Q6P656, Q6P8Y0, Q6PFW1, Q80V31, Q86VS3
Diamond homologs: F6RJC2, Q568D2, Q6P656, Q6P8Y0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1003 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:81134396:G:GT | donor_gain | 1.0000 |
| 15:81135355:GACCG:G | donor_gain | 1.0000 |
| 15:81136553:AC:A | acceptor_gain | 1.0000 |
| 15:81136554:C:CA | acceptor_gain | 1.0000 |
| 15:81136554:C:G | acceptor_gain | 1.0000 |
| 15:81136555:G:A | acceptor_gain | 1.0000 |
| 15:81143660:A:AG | acceptor_gain | 1.0000 |
| 15:81143661:G:GG | acceptor_gain | 1.0000 |
| 15:81143661:GTT:G | acceptor_gain | 1.0000 |
| 15:81143661:GTTGT:G | acceptor_gain | 1.0000 |
| 15:81134381:G:GT | donor_gain | 0.9900 |
| 15:81134395:GGAG:G | donor_gain | 0.9900 |
| 15:81134396:GAGGT:G | donor_loss | 0.9900 |
| 15:81134399:G:GA | donor_loss | 0.9900 |
| 15:81134400:T:G | donor_loss | 0.9900 |
| 15:81135265:TTTAG:T | acceptor_loss | 0.9900 |
| 15:81135267:TA:T | acceptor_loss | 0.9900 |
| 15:81135268:A:AC | acceptor_loss | 0.9900 |
| 15:81135268:A:AG | acceptor_gain | 0.9900 |
| 15:81135269:G:GG | acceptor_gain | 0.9900 |
| 15:81135269:G:GT | acceptor_loss | 0.9900 |
| 15:81135269:GGA:G | acceptor_gain | 0.9900 |
| 15:81135325:G:GT | donor_gain | 0.9900 |
| 15:81135356:ACCGG:A | donor_loss | 0.9900 |
| 15:81135358:CGG:C | donor_loss | 0.9900 |
| 15:81135359:GGTAA:G | donor_loss | 0.9900 |
| 15:81135360:G:GC | donor_loss | 0.9900 |
| 15:81135360:G:GG | donor_gain | 0.9900 |
| 15:81135361:T:A | donor_loss | 0.9900 |
| 15:81136514:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
1989 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:81148417:T:A | W264R | 0.987 |
| 15:81148417:T:C | W264R | 0.987 |
| 15:81143674:A:C | S164R | 0.986 |
| 15:81143676:T:A | S164R | 0.986 |
| 15:81143676:T:G | S164R | 0.986 |
| 15:81134372:T:A | W15R | 0.983 |
| 15:81134372:T:C | W15R | 0.983 |
| 15:81143761:T:A | W193R | 0.983 |
| 15:81143761:T:C | W193R | 0.983 |
| 15:81134374:G:C | W15C | 0.982 |
| 15:81134374:G:T | W15C | 0.982 |
| 15:81135285:T:C | F29L | 0.978 |
| 15:81135287:C:A | F29L | 0.978 |
| 15:81135287:C:G | F29L | 0.978 |
| 15:81143763:G:C | W193C | 0.976 |
| 15:81143763:G:T | W193C | 0.976 |
| 15:81148419:G:C | W264C | 0.975 |
| 15:81148419:G:T | W264C | 0.975 |
| 15:81143816:T:A | V211D | 0.973 |
| 15:81147877:T:A | I219N | 0.972 |
| 15:81136696:A:C | S114R | 0.971 |
| 15:81136698:C:A | S114R | 0.971 |
| 15:81136698:C:G | S114R | 0.971 |
| 15:81148413:C:A | N262K | 0.969 |
| 15:81148413:C:G | N262K | 0.969 |
| 15:81138097:T:C | F147L | 0.967 |
| 15:81138099:T:A | F147L | 0.967 |
| 15:81138099:T:G | F147L | 0.967 |
| 15:81148418:G:C | W264S | 0.967 |
| 15:81138098:T:C | F147S | 0.965 |
dbSNP variants (sampled 300 via entrez): RS1000118350 (15:81146406 A>C), RS1000179714 (15:81126775 G>A,C), RS1000190643 (15:81114716 T>A,G), RS1000245362 (15:81120439 C>T), RS1000296521 (15:81133924 C>A,T), RS1000335176 (15:81140217 T>G), RS1000362130 (15:81107933 T>C), RS1000417581 (15:81107580 C>A), RS1000505639 (15:81102856 G>A,C,T), RS1000553882 (15:81107493 G>T), RS1000586440 (15:81107748 T>TA), RS1000593782 (15:81126305 GTT>G), RS1000695990 (15:81109516 C>A), RS1000729100 (15:81114403 G>A), RS1000729623 (15:81120854 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_10 | Body mass index | 2.000000e-08 |
| GCST010242_92 | HDL cholesterol levels | 3.000000e-08 |
| GCST010396_314 | Gut microbiota (bacterial taxa, hurdle binary method) | 6.000000e-06 |
| GCST010866_63 | Coronary artery disease | 4.000000e-10 |
| GCST011365_109 | Myocardial infarction | 7.000000e-07 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, increases expression | 2 |
| Smoke | increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| monobutyl phthalate | decreases methylation, increases abundance | 1 |
| S-(1,2-dichlorovinyl)cysteine | decreases expression | 1 |
| monomethylpropion | affects expression | 1 |
| mono-benzyl phthalate | decreases methylation, increases abundance | 1 |
| abrine | increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Arbutin | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Coal | increases abundance, increases expression | 1 |
| Cuprizone | affects cotreatment, increases expression | 1 |
| Haloperidol | affects cotreatment, increases expression | 1 |
| Phthalic Acids | decreases methylation, increases abundance | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.